Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03149887 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair
A Phase 4 study, sponsored by Steven Orebaugh.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT03149887 is a Phase 4 study that has completed, run by Steven Orebaugh. The registered enrollment target is 54 participants.
The verdict
NCT03149887, a Phase 4 study, has completed, sponsored by Steven Orebaugh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
Liposomal bupivacaine, a long-acting form of bupivacaine, has been found to be effective for postoperative pain control after total knee, total hip and total shoulder arthroplasty. We are conducting a randomized, controlled trial to evaluate pain control after arthroscopic rotator cuff repair in ambulatory patients, comparing standard care in the control group, with standard care plus the addition of injection of liposomal bupivacaine in the experimental group.
Interventions
- DRUG Placebo
- DRUG Liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2019-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03149887
The ClinicalTrials.gov registry entry for NCT03149887 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steven Orebaugh, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03149887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03149887 about?
NCT03149887 is a clinical study titled "Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair". Liposomal bupivacaine, a long-acting form of bupivacaine, has been found to be effective for postoperative pain control after total knee, total hip and total shoulder arthroplasty. We are conducting a randomized, controlled trial to evaluate pain control after arthroscopic rotator cuff repair in amb...
What is the current status of trial NCT03149887?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2017-12-05. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT03149887?
The interventions under investigation include: Placebo (DRUG), Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03149887?
This trial is sponsored by Steven Orebaugh, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.